ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2078

A Proposed Simple 3-Variable Index for Identification of Fibromyalgia, Analogous to Classification Criteria for RA and SLE

Sung-Hoon Park1, Jung-Yoon Choe2, Seong-Kyu Kim3, Hwajeong Lee4 and Theodore Pincus5, 1Internal Medicine, Arthritis and Autoimmunity Research Center, Catholic University of Daegu School of Medicine, Daegu, South Korea, 2Division of Rheumatology, Catholic University of Daegu School of Medicine, Daegu, South Korea, 3Devision of Rheumatology, Department of Internal Medicine, Arthritis & Autoimmunity Research Center, Catholic University of Daegu School of Medicine, Daegu, South Korea, 4Internal medicine, Catholin university of Daegu School of medicine, Daegu, South Korea, 5rheumatology, Rush univeristy medical center, Chiacago, IL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Classification criteria and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus

Session Type: Abstract Submissions (ACR)

Background/Purpose : A cumulative index that includes various quantitative data has been useful in developing classification criteria for various rheumatic diseases, including rheumatoid arthritis (RA)1 and systemic lupus erythematosus (SLE).2 Previous reports indicate that self-report patient scores on a multidimensional health assessment questionnaire (MDHAQ) provide clues to identify patients with fibromyalgia (FM).3,4 Since the diagnosis of FM is made primarily on the basis of patient report of pain and other symptoms, a cumulative scale of quantitative patient self-report scores as well as a physician estimate of a level of FM might be useful to identify patients with FM. To analyze a simple 3-variable cumulative scale to identify patients with FM, and distinguish them from patients with RA, SLE, and ankylosing spondylitis (AS) seen in a usual care setting in Korea.

Methods : All patients seen at a Korean rheumatology setting complete an MDHAQ/RAPID3 (routine assessment of patient index data), which includes scores for physical function, visual analog scales (VAS) for pain, global status and fatigue, and a list of 60 symptoms as a checklist review of symptoms. Physicians also complete a RHEUMDOC form which includes a 0-10 VAS physician global estimate of patient status, and 0-10 VAS subscales for inflammation, damage, and level of symptoms not explained by inflammation and damage, such as FM. Preliminary cross tabulations were performed to compare scores for MDHAQ variables in patients with FM versus RA, SLE, and AS. Based on these preliminary analyses, a 3-variable cumulative scale was developed: 1) VAS pain score of ≥5 out of 10, 2) symptom checklist of ≥15 out of 60 symptoms, and 3)physician estimate of FM level ≥3 out of 10. The numbers of patients with FM, RA, SLE and AS who scored 0, 1, 2, or 3 were computed; chi square tests and receiver operator curves (ROC) were used to analyze statistical significance.

Results : Data were available concerning 32 patients with FM, 18 with AS, 17 with SLE and 277 with RA. Overall, 53% of patients with FM had scores of 2 or 3 of these criteria, compared to 5.5% with AS, 20.2% with RA and 5.8% with SLE (p ≤0.001). ROC area was 0.734, with standard error of 0.047 and 95% confidence interval of 0.642-0.826. A score of 2, which does not require any physician data, was associated with a positive likelihood ratio for FM of 2.9, sensitivity of 53.1 and specificity of 81, with 79% correctly classified. A score of 3 was associated with a positive likelihood ratio for FM of 7.1, with 90% correctly classified.

Dx

FM score, N (%) of patients

Total N

0

1

2

3

AS

10 (55.6%)

7 (38.9%)

1 (5.5%)

0

18

FM

5 (15.6%)

10 (31.3%)

9 (28.1%)

8 (25.0%)

32

RA

130 (46.9%)

91 (32.9%)

45 (16.2%)

11 (4.0%)

277

SLE

8 (47.1%)

8 (47.1%)

1 (5.8%)

0

17

Total

153 (44.5%)

116 (33.7%)

56 (16.3%)

19 (5.5%)

344

Chi square=38.32, p<0.001


Conclusion : A cumulative score analogous to classification criteria for RA or SLE may be useful in helping to identify FM. A limitation of this study is that it did not identify patients with a diagnosis of RA, SLE,or AS who might also have FM, who may account for patients with inflammatory rheumatic diseases and scores of 2 or 3 on the preliminary FM index.


Disclosure:

S. H. Park,
None;

J. Y. Choe,
None;

S. K. Kim,
None;

H. Lee,
None;

T. Pincus,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-proposed-simple-3-variable-index-for-identification-of-fibromyalgia-analogous-to-classification-criteria-for-ra-and-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology